Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News Feature articles General Information Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide News In Focus Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

MOH releases Guidelines for Centralized Drug Purchase of Medical Institutions (w... The Ministry of Health recently released the full text of its Guidelines for Centralized Drug Purchase of Medical Institutions and this article is an exclusive thorough s... (7/23/2010) China: Behind the Screen (External) (7/30/2010) MOH releases Guidelines for Centralized Drug Purchase of Medical Institutions (with through summary) (7/23/2010) China's Pharma Market: Friend or Foe? (External) (7/19/2010) China issues new regulations on centralized hospital drug purchases (with full summary) (7/15/2010) Emerging Markets Under Anti-Corruption Microscope (7/15/2010) Biospectrum: Top 20 deals in Pharma, Biotech & Medical Sector - Asia Pacific (2010) (7/9/2010) Another Shoe Drops at the SFDA as Drug Pricing Reform Takes Center Stage (6/29/2010) Uptake of Novel Therapies in China and the Impact of Geography, Insurance and Patient Income Levels (6/29/2010) Why China Is Now the World Leader in Genome Sequencing Capacity (External) (6/28/2010) NDRC seeks comments on draft drug pricing regulation from industry associations (with summary and comments) (6/3/2010) Is the NDRC Bluffing or Signaling A New Round of Price Cuts? (5/28/2010) The Increased Use of Nanotechnology in China's Biotech Industry (5/26/2010) Drug Price Reform Looms as SFDA Faces More Challenges (5/24/2010) Does the Calculus of Big Pharma's Emerging-Market Growth Strategies Add Up? (External) (5/11/2010) IMS: Market Trends of the Chinese Hospital Drug Market in 2009 (5/10/2010) USFDA under pressure over Chinese heparin investigations  (7/30/2010) Merck CEO is "very excited" about future in China  (7/30/2010) Charles River and WuXi PharmaTech agree to terminate merger deal  (7/30/2010) Shanghai No.1 Pharmacy to reorganize Chongming Pharma  (7/30/2010) WHO to establish cooperative information center in China  (7/30/2010) (free) Colorectal cancer prevalence rises fast in China  (7/30/2010) Vice Health Minister meets J&J delegation  (7/30/2010) Chinese monoclonal antibody drug sales expected to grow sharply  (7/29/2010) Rising number of pharma firms outsource IT responsibilit... Sanofi-Aventis in talks with Genzyme for acquisition Asthma drug sales to decline in leading Western markets US probes pharma corruption violations abroad USFDA advisory panels vote to keep Avandia on the market... Chinese monoclonal antibody drug sales expected to grow sharply... IMS reports Chinese hospital drug sales results for 1Q/2010 IMS releases data on top drug products and therapeutic classes ... SMEI: Pharmaceutical industry and market performance in 2009 IMS Health: China leads the pharma market in Asia Pacific Merck CEO is "very excited" about future i... Charles River and WuXi PharmaTech agree to terminate merger ... Shanghai No.1 Pharmacy to reorganize Chongming Pharma Legend Capital places bet on China's fledgling retail pharma... Sinovac completes its vaccine manufacturing facility SFDA seeks comments on regulation for drug quality in me... Guangzhou issues maximum retail prices following review ... Beijing initiates ex-manufacturer drug price investigati... New pharma water pollutant discharge standards became ef... MOH initiates a new round of anti-corruption campaign Stella pharma gains Chinese and U.S. patents for IC/PBS drug... China and Taiwan signs bilateral agreement on IPR Chinese Tort Law went into effect on July 1 Three drug companies sue Chongqing Municipal Health Departme... India obstructs Lizvon's attempt to patent medicinal plants ... USFDA under pressure over Chinese heparin investigations... India to step up regulation of Chinese bulk drug imports... India bans API import from ten Chinese producers New steroid API manufacturing facility begins operation ... China to set restrictions on investments in vitamin C se... Three innovative antibody drugs under development in Bei... Stallergenes announces phase III results of its asthma i... China to launch the world's first gastric vaccine SFDA approves new anti-depressant of SIPI and Shanghai M... Abbott launches new diabetic nutrition in China WHO to establish cooperative information center in China... Colorectal cancer prevalence rises fast in China MOH seeks comments for essential drug purchase policy China initiates large scale survey of chronic disease pr... MOH reviews progress of public hospital reform Biostar Pharma appoints new CFO IMS Health appoints new GM for China Nepstar appoints new CEO Jiangbo Pharma appoints new CEO Senior executive moves at IMS, Ranbaxy and RDPAC Vice Health Minister meets J&J delegation Upcoming Event: Pharma Contract Manufacturing Asia 2010 Upcoming Event: Antibody Engineering & Therapeutics ... Upcoming Event: Vaccine Manufacturing World 2010 RNCOS: China's health insurance market offers hugh growt... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON publishes China Pharmace...   Pharma China adds one more dis...   WiCON Launches China Pharmaceu...   Pharma China adds another dist...   Testimonials from subscribers ...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links